RP-HPLC comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2025-12-05. Numbers and descriptions here follow the published literature rather than marketing material.
Serum protein binding dominates the pharmacokinetic profile. The attached chain associates strongly with albumin, shielding the peptide from enzymatic attack and slowing filtration by the kidney. This interaction extends the circulation half-life to roughly one week in humans, which supports weekly administration intervals. An oral version pairs the peptide with an absorption enhancer that transiently alters gastric epithelium, permitting limited uptake; bioavailability by that route is substantially lower than by injection.
Semaglutide belongs to the glucagon-like peptide-1 receptor agonist class, a group of synthetic peptides that imitate an incretin hormone released by intestinal L cells after food intake. Native GLP-1 circulates for only a few minutes because dipeptidyl peptidase-4 cleaves it rapidly. The hormone acts on pancreatic islets, the gastrointestinal tract, and several brain regions. Because the natural peptide is short-lived, development work concentrated on analogues that keep receptor activity while resisting enzymatic breakdown and renal clearance.
The semaglutide sequence is a 31-residue analogue of human GLP-1, altered at three positions relative to the parent hormone. Aminoisobutyric acid replaces alanine at position 8, arginine replaces lysine at position 34, and a lipophilic diacid is attached to lysine 26 through a short linker. These features are reported consistently in the structural literature. The position 8 substitution blocks recognition by dipeptidyl peptidase-4, while the attached chain drives strong, reversible association with a carrier protein in blood.
肽类的主要降解路径包括天冬酰胺脱酰胺、甲硫氨酸氧化、天冬氨酸异构化以及由 β-折叠驱动的聚集，这些反应对 pH 与缓冲液种类较为敏感。磷酸盐、丙二醇与苯酚等辅料会影响局部微环境与界面行为。强制降解研究借助高温、强光、氧化剂与极端 pH 暴露来预测产物谱。关于长期室温存放的数据相对有限，超出标签条件的稳定性仍属开放问题，需要在具体制剂中通过实时与加速试验加以确认。
容器与密封系统同样参与稳定性表现。硅油涂层、胶塞材质与顶空氧含量可能改变聚集速率与氧化水平。分析结果因此需要在完整包装形式下评估，而不能仅凭原料药数据推断。法规文件通常要求同时提交批次数据与代表性容器中的稳定性趋势。
关于降解产物的免疫原性风险，文献中仍有讨论空间。体外聚集水平与临床免疫反应之间的定量关系尚未确立。多数公开研究只报告理化指标，缺少长期随访的对应数据。这一问题在生物类似物比对中尤其受到关注。
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide, GLP-1 receptor agonist | 31 amino acid residues |
| Molecular formula | C187H291N45O59 | free peptide, no counter-ion |
| Approximate mass | 4114 Da | matches theoretical value |
| Receptor target | Glucagon-like peptide-1 receptor | Gs-coupled, cyclic AMP pathway |
| Circulation half-life | About one week in humans | extended by albumin association |
Reverse-phase high-performance liquid chromatography is the standard method for purity assessment, separating the peptide from truncated or oxidized variants. Mass spectrometry confirms molecular mass and detects modifications, while ultraviolet absorbance near 280 nanometers supports concentration measurement through tryptophan and tyrosine residues. Circular dichroism can indicate secondary structure, though the peptide is largely helical in solution, and ion-exchange chromatography resolves charge variants. Purity values above 95 percent are typical for research-grade material. Stability studies track degradation over time under defined conditions.
Lyophilized semaglutide is typically stored at temperatures between minus 20 and minus 80 degrees Celsius for long-term preservation. Short-term storage at 2 to 8 degrees Celsius is common for working aliquots. Repeated freeze-thaw cycles can degrade the peptide and are usually avoided. The molecule is hygroscopic in its solid form, so containers should remain sealed with desiccant. Solutions are less stable than powders and are generally prepared fresh. Light exposure is limited because aromatic residues can undergo photo-oxidation.
Semaglutide dissolves readily in water and in aqueous buffers near neutral pH. Solubility decreases near the isoelectric point, where net charge is minimal. Common laboratory solvents include phosphate-buffered saline and dilute ammonium bicarbonate. Strongly acidic or basic conditions may accelerate hydrolysis. Working concentrations are usually prepared by diluting a concentrated stock. Vial surfaces can adsorb small amounts of peptide at low concentrations, so carrier proteins or low-binding tubes are sometimes used.
Development began in the early 2010s with the goal of extending GLP-1 activity beyond the brief window achieved by native peptide infusion. The earliest approved formulation was a subcutaneous injection given once weekly. A later oral tablet pairs the peptide with an absorption enhancer, sodium N-(8-[2-hydroxybenzoyl] amino) caprylate, usually shortened to SNAC. That carrier lowers local pH and helps the peptide cross gastric tissue. Both routes deliver the same active molecule.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, a gut hormone released after meals. Its backbone retains the GLP-1 sequence but incorporates two substitutions that slow enzymatic breakdown by dipeptidyl peptidase-4. A short polyethylene glycol linker and a C18 fatty diacid are attached to the peptide chain, allowing the molecule to bind serum albumin and remain in circulation far longer than the native hormone. The result is a circulating half-life measured in days rather than the minutes typical of endogenous GLP-1.
Receptor activation occurs at GLP-1 receptors distributed across pancreatic islets, the hypothalamus, and the gastrointestinal tract. Binding triggers G protein signaling that raises cyclic AMP and enhances glucose-dependent insulin release. Because the effect depends on prevailing glucose levels, insulin secretion does not rise when blood sugar is already low. Signaling in the brain and gut also influences appetite and gastric emptying, which is why the compound appears in both metabolic and weight-related research literature.
Two principal therapeutic variants exist under separate regulatory filings, one indicated for glycemic control in type 2 diabetes and one for chronic weight management. Both use the same active molecule; differences lie in formulation strength, titration schedule, and labeling. Regulatory agencies in the United States and European Union approved injectable forms in 2017 and 2018 respectively. An oral tablet formulation received approval later, using a carrier molecule to enhance absorption across the gastric epithelium. Labeling differs by jurisdiction and by indication.
The distinction between established facts and open questions matters here. That the peptide binds the GLP-1 receptor and stimulates insulin release in a glucose-dependent manner is well documented. How individual variability in receptor density, gastric emptying rate, and gut microbiome composition shapes response remains an active research area. Long-term outcomes beyond five years of continuous use are not yet fully characterized in published trials, and several extension studies are ongoing.
Semaglutide is a synthetic peptide analog of glucagon-like peptide-1, a hormone released from intestinal L cells after food intake. The molecule is a 31-amino-acid backbone modified at three positions to resist cleavage by dipeptidyl peptidase-4, the enzyme that degrades native GLP-1 within minutes. A lysine residue at position 26 carries a linker and a C18 fatty diacid, which promotes binding to serum albumin and slows renal clearance. These changes extend the circulating half-life from roughly two minutes to about one week in humans.
Reversed-phase high-performance liquid chromatography with ultraviolet detection is the dominant approach for peptide purity assessment, usually paired with mass spectrometry to confirm molecular mass and sequence. Peptide mapping by enzymatic digestion and tandem mass spectrometry locates modifications such as deamidation and oxidation. Quantitation in plasma matrices can be performed by LC-MS/MS after solid-phase extraction. Method validation follows general guidance on accuracy, precision, linearity, and limits of detection. Comparability of results between laboratories, when no shared reference standard is available, remains an open question.
Stability studies focus on deamidation of asparagine and glutamine residues, oxidation of methionine, and aggregation into higher-order species. The fatty acid side chain adds susceptibility to oxidative change and can promote self-association at high concentration. Lyophilised material is comparatively robust when kept cold and dry, while aqueous solutions require refrigeration and protection from light. Forced degradation experiments under heat, acid, base, and peroxide conditions establish the specificity of each analytical method. Which degradation route dominates under real storage conditions depends on the formulation and stays formulation-specific.
Acids are used as catalysts in industrial and organic chemistry; for example, sulfuric acid is used in very large quantities in the alkylation process to produce gasoline. Some acids, such as sulfuric, phosphoric, and hydrochloric acids, also effect dehydration and condensation reactions. In biochemistry, many enzymes employ acid catalysis.
In 1972, Helmut Hamberger, chief post-doc for Nobel laureate Robert Burns Woodward of Harvard University, sought Jim Waters’ help to the first synthesis of vitamin B12. Dr. Hamberger wanted to purify the positional isomers, which were needed to give him the right compound for the final stages of the synthesis. Working with Dr. Hamberger, the pair took two days to develop a separation, five more days to obtain larger columns to scale up the separation, and three more days to prep his material, successfully isolating and purifying 200 mg of the precursor compound. In 1973, a year after appointing Frank Zenie as its president, Waters Associates moved its headquarters from Framingham to a semi-rural 26-acre (110,000 m2) site in Milford, Massachusetts; Waters became chairman. From 1972 to 1977, sales grew at a 40% compound annual growth rate. The company introduced its M6000 pump, the first high-pressure, high-accuracy pumping system, which won an award from Industrial Research Magazine. In 1973, the company became a public company via an initial public offering on the predecessor to the Nasdaq. By 1978, Waters had a 40% market share in liquid chromatography and was five times bigger than any competitor. By 1979, Dow owned almost 25% of the company. At that time, the company had 1,100 employees and over 10,000 customers. In May 1980, Millipore acquired the company for $167 million and the company was referred to as the Waters Chromatography Division of Millipore.
Canada is divided into 15 terrestrial and five marine ecozones. These ecozones encompass over 80,000 classified species of Canadian wildlife, with an equal number yet to be formally recognized or discovered. Although Canada has a low percentage of endemic species compared to other countries, due to human activities, invasive species, and environmental issues in the country, there are currently more than 800 species at risk of being lost. About 65 percent of Canada's resident species are considered "Secure". Over half of Canada's landscape is intact and relatively free of human development. The boreal forest of Canada is considered to be the largest intact forest on Earth, with approximately 3,000,000 square kilometres (1,200,000 sq mi) undisturbed by roads, cities or industry. Since the end of the last glacial period, Canada has consisted of eight distinct forest regions. Approximately 12.1 percent of the nation's landmass and freshwater are conservation areas, including 11.4 percent designated as protected areas. Approximately 13.8 percent of its territorial waters are conserved, including 8.9 percent designated as protected areas. Canada's first National Park, Banff National Park was established in 1885. Canada's oldest provincial park, Algonquin Provincial Park was established in 1893. Established in 2015, Lake Superior National Marine Conservation Area is the world's largest freshwater protected area. Canada's largest national wildlife region, established in 2018, is the Scott Islands Marine National Wildlife Area.
Common recreational drugs include caffeine, commonly found in coffee, tea, soft drinks, and chocolate; alcohol, commonly found in beer, wine, cocktails, and distilled spirits; nicotine, commonly found in tobacco, tobacco-based products, and electronic cigarettes; cannabis and hashish (with legality of possession varying inter/intra-nationally); and the controlled substances listed as controlled drugs in the Single Convention on Narcotic Drugs (1961) and the Convention on Psychotropic Substances (1971) of the United Nations (UN). Since the early 2000s, the European Union (EU) has developed several comprehensive and multidisciplinary strategies as part of its drug policy in order to prevent the diffusion of recreational drug use and abuse among the European population and raise public awareness on the adverse effects of drugs among all member states of the European Union, as well as conjoined efforts with European law enforcement agencies, such as Europol and EMCDDA, in order to counter organized crime and illegal drug trade in Europe.
== N == NEMS-MS – Nanoelectromechanical systems mass spectrometry NETD – Negative electron-transfer dissociation NICI – Negative ion chemical ionization NRMS – Neutralization reionization mass spectrometry
Sources: en.wikipedia.org
=== Pharmaceuticals === The expiration date of pharmaceuticals specifies the date the manufacturer guarantees the full potency and safety of a drug. Most medications continue to be effective and safe for a time after the expiration date. A rare exception is a case of renal tubular acidosis purportedly caused by expired tetracycline. A study conducted by the U.S. Food and Drug Administration covered over 100 drugs, prescription and over-the-counter. The study showed that about 90% of them were safe and effective as long as 15 years past their expiration dates. Joel Davis, a former FDA expiration-date compliance chief, said that with a handful of exceptions - notably nitroglycerin, insulin and some liquid antibiotics - most expired drugs are probably effective. Shelf life is not significantly studied during drug development, and drug manufacturers have economic and liability incentives to specify shorter shelf lives so that consumers are encouraged to discard and repurchase products. One major exception is the Shelf Life Extension Program (SLEP) of the U.S. Department of Defense (DoD), which commissioned a major study of drug efficacy from the FDA starting in the mid-1980s. One criticism is that the U.S. Food and Drug Administration (FDA) refused to issue guidelines based on SLEP research for normal marketing of pharmaceuticals even though the FDA performed the study. The SLEP and FDA signed a memorandum that scientific data could not be shared with the public, public health departments, other government agencies, and drug manufacturers.
=== Pollution remediation === NASA's microencapsulating technology enabled the creation of "Petroleum Remediation Product," (PRP) which safely cleans petroleum-based pollutants from water. PRP uses thousands of microcapsules—tiny balls of beeswax with hollow centers. Water cannot penetrate the microcapsule's cell, but oil is absorbed into the beeswax spheres as they float on the water's surface. Contaminating chemical compounds that originally come from crude oil (such as fuels, motor oils, or petroleum hydrocarbons) are caught before they settle, limiting damage to ocean beds. PRP microcapsules serve as nutrients to assist naturally occurring microbes in soil or water to biodegrade contaminants.
=== India === According to statistics from the Crisis Intervention Team of LGBT Collective in Telangana, India, in 2024 there had been 15 reported instances of corrective rape in the previous five years. Corrective rape in India typically happens in order to protect the family name, and to prevent abnormal perception by the surrounding community. In India, there is a generally negative attitude towards homosexuality and the fact is that individuals in India who identify as homosexual are victimized at a higher rate. There is also a high level of negativity towards the trans community in India.
protein folding The physical process by which the linear chains of amino acids (i.e. polypeptides) synthesized during translation are changed from random coils into stable, orderly, three-dimensional shapes (i.e. proteins) by assuming a higher-order structure or conformation which permits the protein to be biologically functional, known as its native state. Folding is the consequence of amino acid residues participating in intermolecular electrostatic interactions with each other and with their surroundings, including other molecules, and so is strongly influenced by the particularities of the local chemical environment. The time it takes to properly fold a protein can vary greatly, but the process often begins while chain synthesis is still ongoing. Some chains may have motifs or domains which lack intrinsic order and remain unfolded across a wide range of chemical conditions. Having the correct three-dimensional structure is essential for proper protein function, and misfolded proteins are generally biologically inactive, though mutant folds can occasionally modify functionality in useful ways.
== History == Azvudine was first found in literature in a patent filed by Chang Jun-biao of Zhengzhou University. It received its current name in 2009, when researchers at Roche independently discovered it as a Hep C RNA polymerase inhibitor in vitro. In the following years, Chinese scientists tested it in vitro for a number of targets, most importantly HBV (human and duck) and HTLV-1, two viruses with a reverse transcriptase. It was first proposed as an HIV treatment in 2011, when in vitro tests by the Chang group provided positive results. In 2014, its oral pharmokinetics in rats was elucidated. A phase II study (NCT04109183) was finished in March 2019 by Genuine Biotech. In August 2020, the Chang group found that the substance inhibits vif in vitro. In the same month, China's drug regulator (NMPA) decided to fast-track the approval process, labelling it a first-in-class medication. In July 2021, NMPA granted conditional approval for HIV-1. It was included in the 2021 HIV treatment recommendnation by the Chinese Medical Association and Chinese CDC, published October that year. Curiously, no full results of the trial have been made available for this study in any journal detailing the experiment design as of December 2022. Parts of the results are shown on the drug monograph as well as a 2022 slides deck produced by Genuine for the NHSA available on the latter's website. Azvudine was found to inhibit some coronaviruses in vitro around 2020, leading to an interest in its use in COVID.
Sources: en.wikipedia.org
There is evidence in a variety of species that the hormones oxytocin and vasopressin are involved in the bonding process, and in other forms of prosocial and reproductive behavior. Both chemicals facilitate pair bonding and maternal behavior in experiments on laboratory animals. In humans, there is evidence that oxytocin and vasopressin are released during labor and breastfeeding, and that these events are associated with maternal bonding. According to one model, social isolation leads to stress, which is associated with activity in the hypothalamic-pituitary-adrenal axis and the release of cortisol. Positive social interaction is associated with increased oxytocin. This leads to bonding, which is also associated with higher levels of oxytocin and vasopressin, and reduced stress and stress-related hormones. Oxytocin is associated with higher levels of trust in laboratory studies on humans. It has been called the "cuddle chemical" for its role in facilitating trust and attachment. In the reward centers of the limbic system, the neurotransmitter dopamine may interact with oxytocin and further increase the likelihood of bonding. One team of researchers has argued that oxytocin only plays a secondary role in affiliation, and that endogenous opiates play the central role. According to this model, affiliation is a function of the brain systems underlying reward and memory formation. Because the vast majority of this research has been done on animals—and the majority of that on rodents—these findings must be taken with caution when applied to humans.
=== Initial effects on health assistance === On February 6, 2025, reports indicated that the total number of employees to be retained was 294, out of a total of more than 10,000. Trump declared that agency leaders were "radical left lunatics", while the State Department ordered them to halt virtually all their projects, even if that meant ceasing programs that helped to eradicate smallpox and prevented millions of HIV cases. The freeze in HIV relief programs, including PEPFAR, is estimated to jeopardize treatment access for 20 million people, including 500,000 children. This drastic action led to sudden pauses in over 30 clinical trials for ailments such as HIV, malaria, cholera, cervical cancer, and tuberculosis, leaving participants with medical devices in their bodies and cut off from researchers, likely going against the principles of the Declaration of Helsinki.
There are hydrophobic amino acids and hydrophilic amino acids in protein molecules. After protein folding in aqueous solution, hydrophobic amino acids usually form protected hydrophobic areas while hydrophilic amino acids interact with the molecules of solvation and allow proteins to form hydrogen bonds with the surrounding water molecules. If enough of the protein surface is hydrophilic, the protein can be dissolved in water. When salt is added to the solution, there is more frequent interaction between solvent molecules and salt ions. As a result, the protein and salt ions compete to interact with the solvent molecules with the result that there are fewer solvent molecules available for interaction with the protein molecules than before. The protein–protein interactions thus become stronger than the solvent–solute interactions and the protein molecules associate by forming hydrophobic interactions with each other. After dissociation in a given solvent, the negatively charged atoms from a chosen salt begin to compete for interactions with positively charged molecules present in the solution. Similarly, the positively charged cations compete for interactions with the negatively charged molecules of the solvent. This process is known as salting out. Soaps are easily precipitated by concentrated salt solution, the metal ion in the salt reacts with the fatty acids forming back the soap and glycerin (glycerol). To separate glycerin from the soap, the pasty boiling mass is treated with brine (NaCl solution).
One way is to fuse modular binding sites (e.g., MS2 RNA tagging system, or RIDD-RIAD dock-and-lock system) to the phase-separating domain (e.g., synthetic RNA repeat, or IDP) that recruit "solute" or "client" of interest. Such a modular design enables engineering, optimization, and reusability of each fusion molecule, thus commonly applied in synthetic biology and metabolic engineering. Moreover, by applying a relatively slower binding system (e.g., split GFP), the recruitment of target into synthetic condensate can be fine-tuned by growth and division rates of the living cells. Another way to gain temporal control over the formation and dissolution of biomolecular condensates is by using optogenetic tools. Several different systems have been developed which allow for control of condensate formation and dissolution which rely on chimeric protein expression, and light or small molecule activation. In one system, proteins are expressed in a cell which contain light-activated oligomerization domains fused to IDRs. Upon irradiation with a specific wavelength of light, the oligomerization domains bind each other and form a 'core', which also brings multiple IDRs close together because they are fused to the oligomerization domains. The recruitment of multiple IDRs effectively creates a new biopolymer with increased valency. This increased valency allows for the IDRs to form multivalent interactions and trigger LLPS. When the activation light is stopped, the oligomerization domains disassemble, causing the dissolution of the condensate.
Directed by David Cohen, made by Psychology News 7 November Life and Art, about assisted reproductive technology (ART) and zygote intrafallopian transfer; Debra Hauer gives a talk at Acland Burghley School; Hossam Abdalla (now on the Human Tissue Authority at the Lister Hospital, Chelsea; the assisted zona hatching technique; intracytoplasmic sperm injection; Robert Winston, Baron Winston of Hammersmith Hospital. Directed by Debra Hauer, produced by Christopher Rawlence, made by Hauer Rawlence 21 November Building for Earthquakes, earthquake engineering in Mexico City; Edward Bortugno of the Office of Emergency Services, California; structural engineer Enrique Martinez Romero of Mexico, and the building of the Mexican Social Security Institute; an earthquake was expected near Acapulco in the next ten years; the North Anatolian Fault is the world's most energetic fault; seismologist Polat Gulkan of the Middle East Technical University; Attilla Ansal, editor of the Bulletin of Earthquake Engineering; Müzeher Erciyastepe of the İnşaat Mühendisleri Odası (IMO, Chamber of Engineers); the gecekondu unsafe buildings; the recent 1992 Erzincan earthquake. Narrated by Seán Barrett (actor), directed by Nick Read, produced by Bill Redway, made by October Films 28 November Space Shuttle Discovery, the Johnson Space Center in Texas, and the ACTS satellite (launched in September 1993 on STS-51) and the shuttle pallet satellite (SPAS) system; the 57th mission of the shuttle - STS-51; Commander Frank L.
Sources: en.wikipedia.org
It is a synthetic peptide of 31 amino acids, built to resemble the natural incretin hormone GLP-1. Because of its size and composition it is handled analytically like other therapeutic peptides, using chromatographic and mass spectrometric methods rather than the techniques typical of small organic drugs.
The substitution at position 8 removes the site recognised by dipeptidyl peptidase-4, the enzyme that destroys the native hormone within minutes. The linked lipophilic chain then binds circulating albumin, which further limits access by degradative enzymes and reduces renal loss. Together these features lengthen the effective circulation time considerably.
It acts at the glucagon-like peptide-1 receptor, a G protein-coupled receptor that signals mainly through cyclic AMP. Activation is glucose dependent, meaning insulin release is stimulated more strongly when blood glucose is already elevated. Other tissues carrying the same receptor respond as well, which explains effects beyond glucose control.
冻融过程中冰晶形成与局部浓度升高会促使肽链发生界面吸附和聚集。聚集不仅降低有效含量，还会改变可见异物与不溶性微粒的计数结果。将溶液分装为单次使用的小体积等份可减少循环次数。